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Abstract
Cystic fibrosis (CF) is the most common autosomal reces-
sive disease of the Caucasian population worldwide, with 
respiratory disease remaining the most relevant source 
of morbidity and mortality. Computed tomography (CT) 
is frequently used for monitoring disease complications 
and progression. Over the last fifteen years there has 
been a six-fold increase in the use of CT, which has lead 
to a growing concern in relation to cumulative radiation 
exposure. The challenge to the medical profession is to 
identify dose reduction strategies that meet acceptable 
image quality, but fulfil the requirements of a diagnostic 
quality CT. Dose-optimisation, particularly in CT, is 
essential as it reduces the chances of patients receiving 
cumulative radiation doses in excess of 100 mSv, a 
dose deemed significant by the United Nations Scientific 
Committee on the Effects of Atomic Radiation. This 
review article explores the current trends in imaging in 
CF with particular emphasis on new developments in 
dose optimisation.
Key words: Cystic fibrosis; Dose optimization; Computed 
tomography; Dose; Ionising radiation; Kalydeco
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Core tip: There is a growing reliance on the use of 
computed tomography (CT) in the management of cystic 
fibrosis (CF), as demonstrated by a six-fold increase in 
the use of CT in CF over the last fifteen years. There 
are concerns over repeated patient exposure to ionising 
radiation and the potential carcinogenic consequences. 
With the ever-increasing life expectancy of patients with 
CF and a predilection for certain cancers, it is important 
to be aware of cumulative radiation exposure from 
radiological imaging. Dose-optimisation, particularly in 
CT, is therefore essential.
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INTRODUCTION
Cystic fibrosis (CF) is the most common autosomal 
recessive disease of the Caucasian population world­
wide, with an incidence of approximately 1 in 3000 
live births[1]. This multisystem disorder is characteri­
sed by irreversible lung destruction, gastrointestinal 
malfunction and exocrine insufficiency. Respiratory 
disease remains the most relevant source of morbidity 
and mortality, and accounts for over 80% of deaths[2]. 
Consequently, thoracic imaging plays a pivotal role in 
monitoring disease complications and progression. 
Computed tomography (CT) in particular has been 
increasingly used to evaluate CF patients. Over the last 
15 years there has been almost a 6­fold increase in the 
use of CT scanning in CF[3]. This trend can be attributed 
to the widespread availability of CT, rapid acquisition 
time and the high sensitivity and specificity for lung and 
gastrointestinal disease. However, there are growing 
concerns over repeated patient exposure to ionising 
radiation and the potential carcinogenic consequences. 
With the ever­increasing life expectancy of CF patients 
and a predilection for certain cancers, cumulative 
radiation exposure from radiological imaging is receiving 
increasing scrutiny[4,5]. This review explores the current 
imaging trends in CF with particular emphasis on new 
developments in dose optimisation.
CT USE AND CUMULATIVE EFFECTIVE 
DOSE 
During their lifetime, it is estimated that CF patients will 
have on average 3.2 thoracic CT scans (range 0­13)[6], 
which results in cumulative effective doses (CEDs) in 
excess of the general population. There are many rea­
sons for this including the length of time patients suffer 
from the disease and the accuracy of CT in the setting 
of CF. Thoracic imaging often begins during infancy; as 
the earliest radiological manifestation of CF, mucous 
plugging, can be detected using radiological imaging. 
As the illness progresses, scanning is often required to 
assess deteriorating lung structure and function caused 
by chronic infection and inflammation secondary to 
bronchiectasis. 
Quantification of CF bronchiectasis using CT bron­
chiectasis scores has been found to be more sensitive 
for assessing the degree of lung destruction, compared 
with pulmonary function test (PFT) parameters obtained 
through PFT[7,8]. In recent years studies have reported 
discordance between changes in CT score and PFTs 
within patient cohorts. In essence, both investigations 
look at different aspects of the disease; CT assesses 
structural change while PFT’s evaluate lung function. In 
one paper, CT bronchiectasis scores deteriorated 70% 
faster than PFT parameters, including forced expiratory 
volume in one second in a third of adults and children 
studied, suggesting that CT is more sensitive than PFT 
assessment at detecting deterioration[7].
The poor sensitivity of PFT’s for changes in lung 
function and the ability of CT to rapidly track declining 
lung function, has implications for use of CT imaging 
for disease management, and CT may provide useful 
information to inform management decisions such 
as when to escalate drug therapy or when lung tran­
splantation is necessary[9­11]. Multiple studies have also 
demonstrated that CT is more sensitive than chest 
radiography in detecting pulmonary deterioration[12­15].
This increased utilisation of CT further increases the 
lifetime CED in these patients. A recent multi centre 
study of CT in CF patients between 1990­2005 showed 
that CT scores were a significant independent predictive 
factor for survival post­transplant[16]. Information gained 
from CT is therefore very useful, considering that up 
to one­third of CF patients will meet criteria for lung 
transplantation[13]. 
Assessment of disease severity by CT provides 
a more objective, reproducible and accurate rep­
resentation of patient’s disease burden. Clinical trials 
increasingly use CT to monitor response to antibiotics 
and gene therapy in the treatment of CF[17,18]. Although 
quantification of changes in disease severity by CT 
closely correlates with the frequency of infective exa­
cerbations and disease progression[19,20], one must 
remain cognisant of the radiation dose incurred from 
this method of assessment[21]. Recent studies have 
shown that the dose from dose optimised CT scans 
is equivalent to one­third of one year’s background 
radiation[22]. Perhaps the risk of sequential scanning 
is justified due to the high morbidity and reduced life 
expectancy related to CF[23,24]. 
The radiation dose incurred by patients with CF 
through medical imaging has recently been studied in 
Ireland, which has the highest worldwide incidence of 
CF[1]. During the 15­year study period, there was a 5.9 
fold increase in all CT imaging[3,25] with an associated 
increase in CED among hospitalised CF patients[26,27]. 
In fact, the annual CED from medical imaging has 
been steadily increasing over the last 30 years. For 
instance the mean annual effective dose for CF patients 
has increased incrementally from 0.39 mSv to 0.47 
mSv and then to 1.67 mSv per person per year over 
the last three decades. A similar study demonstrated 
comparable findings in a French context, where it was 
found that the mean CED in a cohort of CF patients was 
19.5 mSv (range 2.24­78.5 mSv)[6]. Donadieu et al[6] 
also found that the patient age at the time of their first 
CT scan has decreased from 20 years in those born 
before 1980 to 1.9 years in those born after 1997 again 
reflecting the increased utilisation of CT in this patient 
group. 
O’Connell et al[3] demonstrated that thoracic imaging 
accounted for 46.9% of the total CED, closely followed 
by abdominopelvic imaging, which was responsible 
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for 42.9% of CED. This may be representative of a 
trend to image the thorax, abdomen and pelvis toge­
ther routinely as opposed the chest only. It may also 
reflect increasing use of CT scanning for investigating 
abdominal complications in CF patients, who are living 
longer as a result of improved respiratory treatments, 
which leads to improved life expectancy among CF 
patients; now extending to between 35 and 40 years[28]. 
These changing trends in radiation exposure among CF 
patients need to be closely monitored[29]. 
The expanding use of CT for guidance of medical 
management, particularly in patients with chronic 
relapsing illnesses such as inflammatory bowel disease 
and CF, has highlighted the need for strategies to opti­
mise dose from imaging, especially CT. CT is responsible 
for only 15% of imaging procedures in inflammatory 
bowel disease but contributes over 75% of the CED[30]. 
The use of diagnostic imaging studies which result 
in exposure to ionising radiation in CF patients is of 
particular concern due to the greater vulnerability of 
younger patients to radiation induced injury due to their 
inherent radio­sensitivity[31], early onset of illness and 
greater risk of high cumulative exposures throughout 
their lifelong illness. 
ROLE OF CHEST MAGNETIC RESONANCE 
IMAGING AND OTHER ALTERNATIVES IN 
PATIENTS WITH CF
Although CT is considered the gold standard for as­
sessing CF patients, there may be a role for use of 
complementary imaging modalities such as pulmonary 
magnetic resonance imaging (MRI)[32]. MRI is less 
sensitive for detection of small airways disease (SAD) 
but is superior for assessing functional change such 
as changes in pulmonary perfusion[33,34]. Many authors 
advocate a role for the use of MRI in the follow­up of 
morphological changes in CF, however[35­37], the combin­
ation of MRI with inhaled hyperpolarised helium is also 
gaining in popularity[38­42]. The utilisation of inhaled 
agents such as hyperpolarised helium or xenon gives 
functional information regarding gas exchange. Obvious 
disadvantages are cost and time for acquisition in 
addition to limited usefulness in the ventilated or critical 
patient.
Fluorodeoxyglucose positron emission tomography 
­ CT has been utilised with some success in delineating 
areas of active infection from fibrosis[43,44]. However 
access, cost and radiation dose are clear constraints 
hence mainstream use cannot be advocated.
RADIATION RISK FROM MEDICAL 
IMAGING
There is no proven association between radiation 
exposure in the diagnostic range and the development 
of malignancy. Predictions of the effects of medical­
induced exposure to low­dose ionising radiation are 
largely based on data from the survivors of atomic bomb 
blasts or nuclear accidents. For the purpose of risk estim­
ation, cancer incidence in this cohort was extrapolated 
from doses greater than 100 mSv to doses of a few 
mSv[45], using a linear no­threshold model. However, 
this model is being challenged as it conflicts with the 
current understanding of the biological mechanism of 
radiation­induced injury. Recently, The United Nations 
Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR), reported uncertainty in relation to the 
health effects of low-dose radiation. Based on findings 
from the nuclear accident in Fukushima 2012, doses of 
100 mSv per year were deemed to have no observable 
acute or chronic effects on cancer incidence rates or 
public health[46]. 
The risk of radiation­induced cancer at doses less 
than 100 mSv is believed by some to be too small to be 
distinguishable from other risk factors for development 
of cancer[47,48]. However, a recently published retros­
pective cohort study, studied the risk of leukaemia and 
brain tumours associated with CT scans performed 
during childhood. Based on the findings of the study, the 
authors estimated that in the 10 years after the first CT 
scan was performed in patients younger than ten years, 
that one excess case of leukaemia and one excess case 
of a brain tumour per 10000 head CT scans occurred[49]. 
This association is particularly pertinent in CF where 
the average age at first CT scan is 1.9 years[27]. Some 
studies have suggested that there is an exponential 
increase of radiation induced cancer with decreasing 
age at initial exposure, namely, there is an estimated 
14% lifetime cancer mortality risk per Gy in patients 
first exposed under the age of 14 years compared to a 
5% risk in those first exposed in their 50’s[50,51]. 
It is vital that the radiologist, referring physician 
and technologist ensure that the immediate benefits 
of CT are likely to outweigh the long­term risks before 
performing a CT scan. Refinements in CT scanner 
hardware and software and development of low­dose 
scanning protocol can lead to substantial reductions in 
radiation exposure from CT scanning while preserving 
image quality. These efforts are ensuring that CT scans 
can now be performed at much lower doses and that 
image quality is preserved in­spite of radiation dose 
reductions. 
OPTIMISATION OF CT PARAMETERS
There is major industry and clinical impetus to develop 
and implement strategies that will reduce the effective 
doses incurred by patients undergoing CT without 
sacrificing diagnostic capabilities. The balance between 
image quality and radiation dose is particularly 
important where dose reduction is contemplated. Image 
noise is inversely related to X­ray beam energy and is 
an important determinant of image quality[52]. There are 
several scanning parameters that affect the radiation 
dose associated with CT, namely: Tube current, tube 
voltage, scanning length, collimation, table speed, table 
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Furthermore, there is a general tendency to increase 
the area of coverage to include regions beyond the 
actual region of interest[64]. This increases the scanning 
length and thus unnecessarily increases doses that 
patients receive. It is essential for referring physicians 
to be mindful of this when requesting CT scans and for 
operators to restrict CT examinations to anatomical area 
that requires investigation. In addition, radiosensitive 
structures frequently lie close to the beam pathway. 
Adequate shielding is crucial, especially in the paediatric 
and young adult population whose organs are inherently 
more radiosensitive[65]. Beaconsfield et al[66] studied 
the effect of shielding regions of the body that are not 
included directly in the path of the X­ray beam during 
CT. They reported that with lead protection, thyroid and 
breast radiation doses were reduced by an average 
of 45% and 76% respectively[66]. This is particularly 
relevant in CF where an intrinsic risk of malignancy may 
be coupled with repetitive exposure to ionising radiation, 
rendering them particularly vulnerable.
Automatic exposure control 
There have been many recent technological advances 
aimed at dose optimisation, including automatic expo­
sure control (AEC). Automatic tube current modulation 
(ATCM) is a type of AEC, that works on the premise 
that pixel noise on a CT scan is attributable to quantum 
noise in the projections[67]. By adjusting the tube current 
to follow the changing patient anatomy, quantum 
noise projections can be adjusted to maintain a desired 
level of noise and improve dose efficiency[54]. Modern 
scanners use either one of two methods of ATCM ­ 
namely Z­axis modulation or angular modulation. In 
Z­axis modulation the tube current is adjusted to a user 
selected noise level[68]. Angular modulation on the other 
hand, attempts to render all images with similar noise 
regardless of patient size and anatomy[69]. The main 
advantage of ATCM is a reduction in dose with minimal 
compromise to image quality. This was highlighted by 
Greess et al[70] who reported a mean dose reduction 
of 22.3% for CT scanning of the neck, thorax and 
abdomen in children without loss of image quality. 
Special attention is required in patients with metallic 
prostheses, i.e., heart valves or anatomical shielding. 
As ATCM adapts the tube current based on density 
and attenuation in the region, there is potential for an 
increase in tube current when metal is in the field of 
interest[71]. In the presence of metallic prostheses, the 
use of z-modulation has been reported to result in a 
34.1% increase in the mean tube current time product 
for abdominopelvic CT. It is important to acknowledge 
that this is still substantially less dose than when using 
fixed tube scanning - i.e., there is a reduction in dose 
of almost 30% with ATCM as opposed to fixed tube 
scanning[72]. With that said, it is imperative that we are 
aware of the presence of metallic prostheses in the 
scanning field so that an increase in radiation dose with 
z-modulation technique can be avoided by selection of 
lower maximum milliamperage thresholds or by using 
pitch, gantry rotation time and shielding[53]. 
Modifications of tube current and tube voltage 
have direct effects on radiation dose but also on image 
“mottle” or noise. There is thus a “balancing act” 
between radiation exposure imparted and image quality, 
which can impact ability to detect and characterise 
pathological processes on the CT images. In most CT 
scanners, tube current is adjustable in increments 
from 20 mAs to approximately 400 mAs. In practice, 
reduction in tube current is the most practical means 
of reducing CT radiation dose, with a 50% reduction 
in tube current leading to a 50% reduction in dose[54]. 
This strategy increases image noise and so must be 
validated prior to clinical use. Lucaya et al[55] studied the 
effects of image acquisition using 50 and 180 mAs in 
CT scanning of the chest in children and young adults. 
Imaging with 50 mAs lead to a 72% reduction in dose 
but no difference in image quality compared with ima­
ging at 180 mAs[55]. Another group have shown that 
high­resolution CT images of lung parenchyma acquired 
at 40 mAs yield anatomic information equivalent to 
that obtained at 400 mAs, without significantly affect 
subjective image quality[56].
Tube voltage affects both image noise and tissue 
contrast[57]. For instance, in abdominal CT, most scans 
can be optimally performed at 120 kVp instead of 140 
kVp, resulting in a 20%­40% reduction in radiation 
dose[58]. The cross sectional dimensions of patients must 
be taken into consideration as the attenuation of the 
incident X­ray beam depends on the anatomical region 
being evaluated[59]. Essentially, larger patients require 
a higher tube voltage. This also applies to tube current 
where Donnelly et al[60] have shown that acceptable 
image quality can be produced at 50% reduced tube 
current in patients weighing less than 81.6 kg. However, 
above this weight, images are too noisy. Therefore, 
scanning parameters should be tailored towards the 
patient characteristics, especially body mass index, in 
order to reduce dose. 
Multiple other user-defined controllable parameters 
of CT imaging have an impact on radiation dose. In 
helical scanners, beam collimation, table speed and 
pitch are interlinked parameters that affect the diagno­
stic quality of an image. Pitch is defined as the ratio 
of table feed per gantry rotation to the nominal width 
of the X­ray beam[54]. A faster table speed results in 
a higher pitch and scanning at a higher pitch is more 
dose effective[61]. Technological advances such as sixty­
four and one hundred and twenty eight detector row 
scanners have resulted in higher scanning speeds. 
For instance, a four row scanner with a 0.8 s gantry 
rotation time requires 16 s to scan the entire abdomen. 
An eight row scanner, on the other hand, covers 
the same length in eight seconds[62]. Sixty­four slice 
scanners can acquire a whole body scan in less than 10 
s and static organ imaging in 1 s[63]. This emphasises 
the importance of being aware that if tube rotation time 
is decreased (faster gantry rotation) radiation exposure 
decreases. 
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higher noise index or mixed modulation methods[73]. 
Radiation exposure can be further optimised by 
using X­ray filters, noise reduction filters and newer 
methods of image reconstruction such as iterative recon­
struction (IR), which we will discuss in greater detail at 
a later stage in this article.
IR
As we have already explored in this review, increased 
image noise and reduced image quality are potential 
unfortunate consequences of reducing CT radiation 
dose. Standard CT scanners use filtered back projection 
(FBP) for image reconstruction. However, newer 
algorithms using IR have been introduced to reconstruct 
image data using a system of models which improve 
image noise. IR uses raw data as a building block 
whereby it transforms the measured value of each pixel 
to a new ideal estimate for that pixel[74]. This method 
uses matrix algebra and is repeated until the final 
estimated and ideal pixel values ultimately converge[75]. 
The use of IR extracts noise from CT images acquired 
at reduced exposure preserving image quality and 
interpretability[76]. The main advantage is that IR allows 
significant reductions in radiation dose while maintaining 
satisfactory image quality when compared to traditional 
FBP[74,77]. 
Hybrid IR, which combines both IR and FBP in a 
predefined ratio for image reconstruction, has been 
well validated in coronary CT angiography and for low 
dose CT scanning of the abdomen and pelvis in chronic 
conditions such as inflammatory bowel disease[78]. 
Multiple commercially available hybrid IR packages 
are available ­ these include adaptive statistical iter­
ative reconstruction (ASIR) (GE Medical Systems, 
Milwaukee, WI, United States), adaptive iterative 
dose reduction (AIDR) (Toshiba Medical Systems, 
Tochigi, Japan), image reconstruction in image space 
(Siemens Healthcare, Erlangen, Germany), sinogram­
affirmed IR (Siemens Healthcare) and iDose (Philips 
Healthcare, Best, Netherlands). Craig et al[30] compared 
hybrid IR of low­dose CT abdomen­pelvis datasets with 
conventional­dose CT in Crohn’s disease and reported 
a 74% radiation dose reduction with IR. IR operates on 
list­mode data as opposed to histogrammed projection 
data and can generate an image following just one pass 
through the scan[79]. This results in a shorter scanning 
time and a reduction in radiation­exposure associated 
with CT thorax to a level approaching that of a plain 
radiograph[80]. The use of low dose CT with IR is ideal for 
imaging CF patients and in particular, the paediatric CF 
population.
In relation to thoracic imaging, ASIR has been shown 
to significantly reduce subjective and quantitative image 
noise on both standard and reduced dose chest CT[81]. 
Dose reductions of 46%­80% for thoracic CT can be 
achieved without compromising image quality[82,83]. In 
practice, this translates to substantial dose reductions in 
paediatric CT imaging without substantial compromise 
in image quality, a strategy that can be applied to 
imaging in CF[84]. 
Next generation imaging reconstruction will be 
performed using “pure” IR such as model­based iter­
ative reconstruction (MBIR, Veo, GE Healthcare), 
iterative model reconstruction (Philips Healthcare), 
advanced modeled iterative reconstruction (ADMIRE, 
Siemens Healthcare) and AIDR 3D (Toshiba Medical 
Systems). Pure IR generates high quality images[85] 
with an even greater reduction in dose than hybrid IR, 
for example in excess of 80% dose reduction[86]. MBIR 
facilitates ultra­low dose chest imaging and a number 
of studies suggest that image quality can be maintained 
at doses approaching those of a chest radiograph[87,88]. 
However, the prolonged processing time currently 
limits its use in routine clinical practice especially for 
emergency cases. In the case of outpatient imaging for 
chronic disease assessment, such as in the setting of 
CF, an hour of reconstruction time is acceptable for the 
benefits gained.
DOSE OPTIMISATION PROTOCOLS
The purpose of CT dose optimisation is to obtain a 
diagnostic image with the least amount of radiation. 
Dose optimisation strategies are a priority among 
imaging specialists. Thoracic CT is particularly suited 
to dose optimisation protocols due to the high inherent 
contrast and low radiation absorption of the lung[89]. 
Recent studies have explored the utilisation of low 
dose protocols for thin­section CT in the assessment 
of CF. O’Connor et al[90] compared two non­contiguous 
thin­section protocols: Protocol A (1 mm section with 
an effective dose 0.19 mSv) and protocol B (0.5 mm 
section with an effective dose 0.14 mSv) reconstructed 
using FBP and using a 4­slice CT scanner. Diagnostic 
acceptability was graded as almost excellent for both 
protocols, however, the 0.5 mm section was found to 
be inferior for mediastinal assessment[90]. This study 
emphasised the fact that low­dose thin section CT is 
a viable option for accurately evaluating pathological 
changes in the lungs of CF patients even at doses 
approaching those of a chest radiograph.
As described above, recent advances in the area 
of radiation dose optimization and CT have focussed 
on refinement of IR techniques to allow diagnostic 
quality images to be acquired at significantly reduced 
radiation doses. IR when applied to thoracic imaging in 
CF patients should potentially allow contiguous chest 
imaging at chest X­ray doses which would improve 
scanning time and reduce the requirement for repeated 
patient breath­holds, which has potential for error. 
Contiguous CT scanning through the chest will facilitate 
3D reconstruction that allows more comprehensive 
characterisation of distribution of lung changes, facili­
tates comparison with previous chest radiography 
and may offer potential for virtual bronchoscopy. Most 
recently, Singh et al[91] showed that ASIR reconstructed 
chest CT images can be obtained at 40 mAs/3.5 mGy 
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and still be diagnostically satisfactory.
Thin­section protocols have great potential for 
use in the paediatric CF population where an effective 
dose reduction of 26% can be achieved without com­
promising image quality[92]. There may also be a role 
for low­dose protocols in non­CF bronchiectasis, which 
accounts for 10% of referrals to tertiary respiratory 
centres[15]. In 50% of these new referrals, patients 
are misdiagnosed with asthma until the true diagnosis 
is confirmed at CT[93,94]. Once a diagnosis of CF is 
established, some experts suggest that low­dose CT 
should be performed bi­annually for assessment of lung 
parenchyma and bronchoalveolar structures in place of 
chest radiography[95].
Furthermore, substantial reductions in radiation 
dose can be achieved using only end expiratory CT in 
CF as opposed to combined end inspiratory and end 
expiratory CT. Loeve et al[96] reported a 75% reduction 
in effective dose when using low­dose (0.4 mSv, 110 
kV) end expiratory CT alone while maintaining high 
inter­observer correlation of CF CT scores. Expiratory 
chest imaging can provide useful detail when air 
trapping is suspected, as this may not be appreciated 
on inspiratory CT[97]. Expiratory CT identifies SAD and 
ideally should be controlled by spirometry[98,99]. SAD is 
recognised by the presence of hypo­dense areas within 
areas of mosaic attenuation and it is estimated that one 
third of hypo­dense regions persist over a 2 year period, 
which suggests irreversibility[12]. This may be used as a 
separate marker of pulmonary disease in conjunction 
with CT bronchiectasis scores.
As a large proportion of CF patients are in the pae­
diatric age group, compliance with scanning methods 
can be difficult to achieve. Methods of optimising patient 
cooperation help maximise the information obtained 
from CT by reducing breathing artefact and the need for 
repeat imaging. Training in breath holding techniques, 
lateral decubitus positioning or spirometry may prove 
beneficial in this regard. In children less than 5 years 
old, sedation may be required to avoid multiple scans 
due to movement or inability to follow instructions[100]. 
Surprisingly, there are no clear data on how CT­
guided decision making affects outcome in CF pati­
ents[101]. Owing to the accurate depiction of disease 
progression, however, low­dose CT scans are regularly 
used to guide management in clinical practice. In many 
dedicated CF centres, dose­optimised CT is performed 
bi­annually. PFT’s are often used in conjunction with 
CT as part of a multi­modal assessment, especially 
between CT scans. Disease models that encompass 
age, gender, CT and PFT’s can be used as a guide to 
predict frequency of infective exacerbations or the 
rate of decline in lung function. Although these models 
are not yet fully validated, they represent a move 
towards personalised treatment. For instance, some 
“low­risk” patients may only need CT scans every 
three years as opposed to “high­risk” patients who 
may need annual scanning. The 2009 CF guidelines 
do not recommend any specific scanning frequency or 
interval but recommend CT in symptomatic patients 
who fail to respond to basic intervention[102]. Ideally, CF 
management should be personalised and based on risk 
stratification.
SCREENING IN RESPIRATORY DISEASE
Dose optimisation scanning techniques have facilitated 
the use of CT as first line imaging and are gaining popu-
larity for screening of benign and malignant respiratory 
conditions. Most notably, The American Association 
for Thoracic Surgery recently published guidelines on 
screening for lung cancer, which recommend annual 
dose­optimised CT screening for patients aged 55­79 
year with a greater than 30 years’ pack history[103­105]. 
These guidelines were derived from the National Lung 
Screening Trial, which established the ability of dose­
optimised CT to decrease lung cancer specific mortality 
by 20% in a screened population[104]. As the role of CT 
in the medical arena expands, so does the need for 
dose­optimisation strategies so that low dose scanning 
becomes commonplace. 
PHYSICIAN AWARENESS
Increasing concern has recently been expressed in 
the literature that the knowledge of referring doctors 
regarding the radiation doses incurred during diagnostic 
radiological procedures is inadequate[106]. Lee et al[107] 
found that 75% of physicians underestimate the dose 
from a CT scan. This is interesting considering the 
integral and expanding role that CT plays across all 
medical specialities and the utilisation of CT in the 
hospital setting where CT accounts for 15% of the 
workload of an average radiology department[108]. This 
shortcoming is also evident in medical students. O’
Sullivan et al[109] assessed medical students’ awareness 
of radiation exposure associated with diagnostic imaging 
and found that only two­thirds of students knew that 
CT used ionising radiation. This lack of awareness 
becomes particularly pertinent when one considers the 
number of patients who receive inappropriate or repeat 
examinations[64,110]. Fortunately, education in clinical 
radiology positively impacts on knowledge of radiation 
exposure associated with diagnostic imaging, which 
supports the Eurotom 97 directive for the integration 
of radiation protection instruction into medical school 
curriculum[111]. As seen in the “Image wisely” and “Image 
gently” campaigns, a three­tiered approach to radiation 
protection is strongly recommended: The as low as 
reasonably achievable principal, justification of the 
imaging procedure and dose limitation[112,113]. In short, 
the best way to reduce the radiation dose to patients 
is to avoid unnecessary CT exams and to look for 
alternative diagnostic imaging modalities which either 
avoid radiation exposure or result in less exposure than 
modalities[114]. Education of medical undergraduates and 
postgraduates is fundamentally important to ensure 
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that radiation protection issues are considered when 
physicians choose the diagnostic imaging studies for 
their patients. 
A new initiative on this front is the introduction 
of patient radiation dose tracking[115­117]. This entails 
detailed automated recording of all medical radiation 
exposures received by patients. This information can 
be included in individual radiology reports and medical 
files plus can be used to calculate lifetime cumulative 
exposures. This knowledge would then be available at 
the image requesting stage to keep clinicians aware 
of the patients past radiation exposures. Another 
powerful aspect of dose tracking is for quality assurance 
purposes within the imaging department, such that per 
study doses can be reduced to defined international 
standards. 
THE CHANGING FACE OF CF
There is a constant stream of novel approaches to the 
management of CF. Most notably, the development 
of the first disease modifying drug in CF, Kayldeco, 
has opened up a new realm of possibilities using 
genomically­guided medicine[118]. In 2012, Kayldeco was 
approved by the food and drug administration for use 
in CF patients with the G551D mutation. Although this 
particular mutation is only found in approximately 5% 
of CF patients, it represents a significant breakthrough 
as it targets the underlying genetic defect within the 
CFTR gene[119]. Drug trials have demonstrated that 
Kalydeco can markedly improve lung function; lower 
sweat chloride levels and help patients gain weight[120]. 
Research is ongoing into the possible benefits of Kayl-
deco in the most common CF mutation: Delta F508, 
which accounts for 70% of mutations. Results from a 
phase 2 trial of Kalydeco in combination with VX­809 
show a marginal improvement in lung function in people 
who are homozygous for delta F508[68,121]. These deve­
lopments have the potential to significantly improve 
quality of life for CF patients, however, the beneficial 
effects on the architecture of the lung, as seen on 
radiological imaging, have not yet been documented. 
This is an area of potential future research and another 
reason for optimisation of CT scanning protocols. 
RECOMMENDATIONS
There is a growing reliance on the use of CT in the 
management of CF, as demonstrated by the six­fold in­
crease in the use of CT in CF over the last fifteen years. 
Dose­optimised CT reduces the chances of patients 
receiving cumulative radiation doses in excess of 100 
mSv, a dose deemed significant by UNSCEAR. 
Longitudinal studies are needed to define appro­
priate scanning intervals and to assess the impact of CT 
scanning on disease outcome in CF patients. 
Physicians are developing tailored approaches to 
disease surveillance, where scanning intervals are based 
on risk stratification in order to maximise benefit.
CONCLUSION
As modern treatments continue to extend the life 
expectancy of CF patients, cumulative radiation expo­
sure from medical imaging is of increasing significance. 
Medical professionals are challenged with identifying 
CT dose­reduction strategies that strike an acceptable 
balance between image quality and diagnostic accepta­
bility. Dose optimisation strategies have to be continually 
developed and refined in all patients, but particularly 
those with chronic diseases such as CF, who will require 
radiological imaging throughout their lifetime.
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